Intuitive Surgical (NASDAQ:ISRG) Stock Rating Lowered by Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

A number of other equities analysts also recently commented on the company. UBS Group set a $600.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. HSBC increased their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Trading Up 2.2%

Shares of NASDAQ ISRG opened at $560.00 on Friday. The stock has a market cap of $200.75 billion, a P/E ratio of 74.07, a PEG ratio of 4.94 and a beta of 1.62. The business’s fifty day simple moving average is $471.89 and its 200-day simple moving average is $501.11. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.84 EPS. On average, equities analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, insider Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $546.27, for a total value of $1,529,556.00. Following the completion of the sale, the insider directly owned 17,120 shares of the company’s stock, valued at $9,352,142.40. The trade was a 14.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total transaction of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 98,078 shares of company stock worth $51,445,892 over the last three months. Company insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of large investors have recently made changes to their positions in the company. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. Kilter Group LLC purchased a new stake in Intuitive Surgical in the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter valued at $27,000. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the 1st quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.